Displaying drugs 9051 - 9075 of 9953 in total
CTT-1057
CTT-1057 is under investigation in clinical trial NCT03427476 (CTT1057, a Small Molecular Inhibitor of PSMA, as a Novel Imaging Agent of Neovascularization in Renal Cell Carcinoma).
Investigational
(S)-DES-ME-AMPA
Experimental
3,4-Dihydroxycinnamic Acid
Experimental
Investigational
Para-Iodo-D-Phenylalanine Hydroxamic Acid
Experimental
TU-514
Experimental
Amido Phenyl Pyruvic Acid
Experimental
1,2-Dipalmitoyl-Phosphatidyl-Glycerole
Experimental
Phenylalanine-N-Sulfonamide
Experimental
3'-Oxo-Adenosine
Experimental
5,6-Cyclic-Tetrahydropteridine
Experimental
2-[4-(2,4-Dichlorophenoxy)Phenoxy]Propanoic Acid
Experimental
Glyphosate
Experimental
Alanosine
An amino acid analogue and antibiotic derived from the bacterium Streptomyces alanosinicus with antimetabolite and potential antineoplastic activities.
Investigational
KOS-1584
KOS-1584 is a second-generation epothilone. Epothilones are anticancer agents with a taxane-like mechanism of action that have demonstrated activity in taxane-resistant tumors. KOS-1584 is a second-generation compound with increased potency, favorable tissue distribution, and ease of formulation.
Investigational
CYCLOHEXYL-NORSTATINE
Experimental
Guvacine
Guvacine is a pyridine alkaloid found in the Areca nut (also known as the Betel nut). It is an experimental drug with no approved indication. Experimental studies are still being investigated to determine all of the physiological effects and mechanisms of action of guvacine. Currently it has been determined that...
Experimental
Famphur
Vet approved
PG-701
Hydroxytriptolide has been investigated for the treatment of Rheumatoid Arthritis.
Investigational
Displaying drugs 9051 - 9075 of 9953 in total